Tempest Therapeutics, Inc. Common Stock
Symbol: TPST (NASDAQ)
10.50
▼ (-4.55%) -0.500
Company Description:
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
Key Stats
- Today's Open: $11
- Today's High: $11.155
- Today's Low: $10.335
- Today's Volume: 73.91K
- Yesterday Close: $11
- Yesterday High: $11.1414
- Yesterday Low: $10.8178
- Yesterday Volume: 51.91K
- Last Min Volume: 0
- Last Min High: $10.5
- Last Min Low: $10.467
- Last Min VWAP: $0
Company Profile
- Name: Tempest Therapeutics, Inc. Common Stock
- Website: https://www.tempesttx.com
- Listed Date: 2021-06-28
- Location: BRISBANE, CA
- Market Status: Active
- CIK Number: 0001544227
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $48.18M
- Round Lot: 100
- Outstanding Shares: 4.44M
- Asset Type: CS
RECENT FILINGS FOR TPST
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-13 | SCHEDULE 13D/A | View |
| 2025-08-11 | 10-Q | View |
| 2025-08-11 | 8-K | View |
| 2025-06-12 | 8-K | View |
| 2025-06-12 | 424B5 | View |
| 2025-06-11 | 8-K | View |
| 2025-06-06 | 8-K | View |
| 2025-05-13 | 10-Q | View |
| 2025-05-13 | 8-K | View |
| 2025-04-30 | 10-K/A | View |
| 2025-04-28 | 8-K | View |
| 2025-04-18 | 8-K | View |
| 2025-04-09 | 8-K | View |
| 2025-04-07 | 8-K | View |
| 2025-03-27 | S-8 | View |
| 2025-03-27 | 10-K | View |
| 2025-03-27 | 8-K | View |
| 2025-02-11 | SCHEDULE 13D/A | View |
| 2025-02-06 | 424B5 | View |
| 2025-01-27 | EFFECT | View |
Latest News on TPST